Last reviewed · How we verify
Tegaderm Hydrogel
Tegaderm Hydrogel is a moisture-donating wound dressing that maintains a moist healing environment by absorbing exudate and providing hydration to dry or necrotic tissue.
Tegaderm Hydrogel is a moisture-donating wound dressing that maintains a moist healing environment by absorbing exudate and providing hydration to dry or necrotic tissue. Used for Partial and full-thickness wounds, Pressure ulcers, Diabetic foot ulcers.
At a glance
| Generic name | Tegaderm Hydrogel |
|---|---|
| Sponsor | Healthpoint |
| Modality | Small molecule |
| Therapeutic area | Wound Care |
| Phase | FDA-approved |
Mechanism of action
The hydrogel formulation absorbs wound fluid while simultaneously releasing water to rehydrate dry, devitalized tissue, promoting autolytic debridement and facilitating the body's natural healing processes. This moist wound environment supports granulation tissue formation and epithelialization while protecting the wound from bacterial contamination and external trauma.
Approved indications
- Partial and full-thickness wounds
- Pressure ulcers
- Diabetic foot ulcers
- Venous leg ulcers
- Surgical wounds
- Burn wounds
- Donor sites
Common side effects
- Skin maceration (excessive moisture)
- Allergic contact dermatitis
- Wound infection
Key clinical trials
- Exciflex for Chronic Wound Therapy (NA)
- Human Repeat Insult Patch Test of Wound Dressings (PHASE1)
- Effectiveness Comparison of Skin Micro-grafts vs Meshed Split Thickness Skin Grafts (PHASE4)
- Antimicrobial Activity of IV Clear™ Dressing - Prevention of Antimicrobial Regrowth (PHASE1)
- Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds (NA)
- Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tegaderm Hydrogel CI brief — competitive landscape report
- Tegaderm Hydrogel updates RSS · CI watch RSS
- Healthpoint portfolio CI